Manufacturers Life Insurance Company, The Cerevel Therapeutics Holdings, Inc. Transaction History

Manufacturers Life Insurance Company, The

$109 Billion
Q4 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$38.96 - $42.75 $958,727 - $1.05 Million	-24,608 Reduced 76.76%	7,450 $304,000
Q1 2024 May 14, 2024	SELL	$40.88 - $43.27 $195,242 - $206,657	-4,776 Reduced 12.97%	32,058 $1.36 Million
Q4 2023 Feb 13, 2024	SELL	$20.27 - $42.44 $2.48 Million - $5.18 Million	-122,137 Reduced 76.83%	36,834 $1.56 Million
Q3 2023 Nov 15, 2023	BUY	$20.26 - $31.91 $260,847 - $410,841	12,875 Added 8.81%	158,971 $3.47 Million
Q2 2023 Aug 11, 2023	BUY	$23.9 - $35.38 $579,742 - $858,212	24,257 Added 19.91%	146,096 $4.64 Million
Q1 2023 May 15, 2023	BUY	$22.82 - $35.32 $127,153 - $196,803	5,572 Added 4.57%	127,411 $3.11 Million
Q4 2022 Aug 11, 2023	BUY	$25.35 - $31.96 $93,110 - $117,389	3,673 Added 3.11%	121,839 $3.84 Million
Q4 2022 Feb 13, 2023	BUY	$25.35 - $31.96 $93,110 - $117,389	3,673 Added 3.11%	121,839 $3.84 Million
Q3 2022 Aug 11, 2023	BUY	$25.5 - $41.42 $97,996 - $159,177	3,843 Added 3.36%	118,166 $3.34 Million
Q3 2022 Nov 03, 2022	BUY	$25.5 - $41.42 $97,996 - $159,177	3,843 Added 3.36%	118,166 $3.3 Million
Q2 2022 Aug 11, 2023	BUY	$20.62 - $37.15 $101,821 - $183,446	4,938 Added 4.51%	114,323 $3.02 Million
Q2 2022 Aug 15, 2022	BUY	$20.62 - $37.15 $101,821 - $183,446	4,938 Added 4.51%	114,323 $3.08 Million
Q1 2022 Aug 11, 2023	SELL	$23.5 - $35.38 $423,611 - $637,759	-18,026 Reduced 14.15%	109,385 $3.83 Million
Q1 2022 May 20, 2022	BUY	$23.5 - $35.38 $2.11 Million - $3.17 Million	89,596 Added 452.76%	109,385 $3.7 Million
Q4 2021 Feb 16, 2022	SELL	$29.21 - $44.64 $7,740 - $11,829	-265 Reduced 1.32%	19,789 $650,000
Q3 2021 Nov 12, 2021	SELL	$21.26 - $38.85 $2,614 - $4,778	-123 Reduced 0.61%	20,054 $592,000
Q2 2021 Aug 12, 2021	BUY	$12.56 - $29.69 $253,423 - $599,055	20,177 New	20,177 $517,000

Others Institutions Holding CERE

# of Institutions

Shares Held

5.01M

Call Options Held

3.3K

Put Options Held

View Full List

About Cerevel Therapeutics Holdings, Inc.

Ticker CERE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 155,752,000
Description
Cerevel Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, engages in the development of various therapies for neuroscience diseases. It is developing emraclidine, a positive allosteric modulator (PAM) that is in phase 1b clinical trials for the treatment of schizophrenia; and Darigabat, a PAM, which is in Phase 2 proof-of-...

More about CERE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.

Account